CRUK/98/001 - SECRAB - A Phase III Study of Sequential v. Synchronous Chemotherapy and Radiotherapy in the Adjuvant Treatment of Early Breast Cancer

Medicine & Life Sciences

1. Anthracyclines 100%
2. Drug Therapy 92%
3. Breast Neoplasms 78%
4. Chemoradiotherapy 75%
5. Radiotherapy 72%
6. Quality of Life 67%
7. Recurrence 60%
8. Methotrexate 33%
9. Fluorouracil 33%
10. CMF regimen 33%
11. Cyclophosphamide 32%
12. Confidence Intervals 31%
13. Adjuvant Chemoradiotherapy 26%
14. Telangiectasis 22%
15. Adjuvant Radiotherapy 20%
16. Women's Health 18%
17. Adjuvant Chemotherapy 17%
18. Pharmacy 17%
19. Random Allocation 17%
20. Global Health 17%
21. Disease-Free Survival 16%
22. Intention 16%
23. Health Status 15%
24. Appointments and Schedules 14%
25. Research Design 13%
26. Radiation 13%
27. Skin 9%
28. Neoplasms 5%